US PATENT SUBCLASS 424 / 192.1
.~ Fusion protein or fusion polypeptide (i.e., expression product of gene fusion)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

184.1  DF  ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) {15}
192.1.~ Fusion protein or fusion polypeptide (i.e., expression product of gene fusion)

DEFINITION

Classification: 424/192.1

Fusion protein or fusion polypeptide (i.e., expression product of gene fusion):

(under subclass 184.1) Subject matter involving a fusion protein or fusion polypeptide, which fusion protein or fusion polypeptide is taken to mean the expression product of a gene fusion.

(1) Note. A gene fusion is a nucleic acid sequence that encodes the complete or partial amino acid sequences of two or more proteins or polypeptides in contiguous fashion, or in noncontiguous fashion, wherein the expressed sequence is ultimately processed to yield the desired fusion protein.